Traumatic muscle injury can be associated with volumetric muscle loss (VML), often leading to permanent functional loss. Until recently, experimental therapies to support muscle regeneration have faced several key limitations, including the challenge of delivering sufficient healing cells to the traumatized area and the inability of conventional tissue transplants to conform to the specific shape of a muscle defect.
This article was originally published on this website.
